Starpharma Holdings Limited - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Starpharma Holdings Limited. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Starpharma Holdings Limited. The Group's principal activity is discovering, developing and commercialising dendrimer products for pharmaceutical, life sciences and other applications. The Group's operation is directed towards the development of precisely defined nano-scale materials for use in pharmaceutical applications with a particular focus on the development of topical vaginal microbicides for the prevention of Human immunodeficiency virus and other sexually transmitted diseases. The Group's main product brands is VivaGel. It operates in Australia and United States.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report